These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 2538668)

  • 1. [Manual for pre- and postoperative patient care. Hepatoma].
    Watabe Y; Mizuno T; Yasukawa M
    Kango Gijutsu; 1989 Jan; 35(2):184-7. PubMed ID: 2538668
    [No Abstract]   [Full Text] [Related]  

  • 2. [Pre- and postoperative nutritional management in patients with hepatoma].
    Tanaka Y; Yokoyama S
    Nihon Rinsho; 1991 Nov; 49 Suppl():466-72. PubMed ID: 1665873
    [No Abstract]   [Full Text] [Related]  

  • 3. Surgical treatment of primary liver cancer.
    Ong GB; Leong CH
    J R Coll Surg Edinb; 1969 Jan; 14(1):42-55. PubMed ID: 4307190
    [No Abstract]   [Full Text] [Related]  

  • 4. Treatment of hepatoma by liver transplantation.
    Schwartz ME; Sheiner P; Mor E; Sung M; Miller CM
    Transplant Sci; 1994 Sep; 4(1):1-3; discussion 3-4. PubMed ID: 7804688
    [No Abstract]   [Full Text] [Related]  

  • 5. Surgical treatment for liver cancer. Current issues.
    Miyazaki M; Kimura F; Shimizu H; Yoshidome H; Ohtsuka M; Kato A; Yoshitomi H; Nozawa S; Furukawa K; Takeuchi D; Suda K; Yoshioka I; Mituhashi N
    Dig Surg; 2007; 24(2):120-5. PubMed ID: 17446706
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Hepatectomy and perisurgical management for heavy drinker with hepatocellular carcinoma].
    Nakayama H; Takayama T; Hemmi A
    Nihon Arukoru Yakubutsu Igakkai Zasshi; 2006 Aug; 41(4):337-42. PubMed ID: 17037342
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Successful hepatectomy of huge hepatocellular carcinoma after shrinkage by transcatheter arterial embolization].
    Hashimoto M; Okazaki M; Koganemaru F; Kataoka A; Igimi H; Shimura H; Higashihara H
    Rinsho Hoshasen; 1988 May; 33(5):621-4. PubMed ID: 2843702
    [No Abstract]   [Full Text] [Related]  

  • 8. [Application of hepatectomy in hepatoma].
    Takasaki T; Kobayashi S
    Kango Gijutsu; 1983 Dec; 29(16):2127-30. PubMed ID: 6317926
    [No Abstract]   [Full Text] [Related]  

  • 9. Liver resection for hepatocellular carcinoma.
    Bryant R; Laurent A; Tayar C; van Nhieu JT; Luciani A; Cherqui D
    Surg Oncol Clin N Am; 2008 Jul; 17(3):607-33, ix. PubMed ID: 18486886
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Nursing care of a patient with ascites due to hepatoma and liver cirrhosis].
    Mizoro S; Yoshida R
    Kango Gijutsu; 1979 Aug; 25(11):72-7. PubMed ID: 228100
    [No Abstract]   [Full Text] [Related]  

  • 11. Evaluation of preoperative hepatic function in patients with hepatocellular carcinoma undergoing hepatectomy.
    Lau H; Man K; Fan ST; Yu WC; Lo CM; Wong J
    Br J Surg; 1997 Sep; 84(9):1255-9. PubMed ID: 9313707
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recovery from liver failure after hepatectomy for hepatocellular carcinoma in cirrhosis: meaning of the model for end-stage liver disease.
    Cucchetti A; Ercolani G; Cescon M; Ravaioli M; Zanello M; Del Gaudio M; Lauro A; Vivarelli M; Grazi GL; Pinna AD
    J Am Coll Surg; 2006 Nov; 203(5):670-6. PubMed ID: 17084328
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Partial hepatectomy for primary hepatoma.
    Dudley P
    Nurs Mirror Midwives J; 1966 Apr; 122(5):7-8. PubMed ID: 4286129
    [No Abstract]   [Full Text] [Related]  

  • 14. Use of hepatectomy and splenectomy to treat hepatocellular carcinoma with cirrhotic hypersplenism.
    Chen XP; Wu ZD; Huang ZY; Qiu FZ
    Br J Surg; 2005 Mar; 92(3):334-9. PubMed ID: 15672441
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of liver function for the application of preoperative portal vein embolization on major hepatic resection.
    Wakabayashi H; Yachida S; Maeba T; Maeta H
    Hepatogastroenterology; 2002; 49(46):1048-52. PubMed ID: 12143199
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk factors for perioperative morbidity and mortality after extended hepatectomy for hepatocellular carcinoma.
    Wei AC; Tung-Ping Poon R; Fan ST; Wong J
    Br J Surg; 2003 Jan; 90(1):33-41. PubMed ID: 12520572
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Advantages and disadvantages of L-TAE in diagnosis and treatment of hepatocellular carcinoma].
    Shimamura Y; Ishii M; Shima Y; Takenaka H; Taniguchi H; Watanabe H; Kitai S; Sugai S; Takahashi A; Kitaya T
    Gan To Kagaku Ryoho; 1988 Aug; 15(8 Pt 2):2535-9. PubMed ID: 2843119
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Experience with infusion and resection in cancer of the liver.
    Stehlin JS; Hafström L; Greeff PJ
    Surg Gynecol Obstet; 1974 Jun; 138(6):855-63. PubMed ID: 4363781
    [No Abstract]   [Full Text] [Related]  

  • 19. [Systemic chemotherapy of hepatocellular carcinoma].
    Okazaki N; Yoshino M; Yoshida T; Hizikata A; Hasegawa H
    Gan To Kagaku Ryoho; 1986 Apr; 13(4 Pt 2):1584-8. PubMed ID: 3015033
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clarification of risk factors for hepatectomy in patients with hepatocellular carcinoma.
    Ishikawa M; Yogita S; Miyake H; Fukuda Y; Harada M; Wada D; Tashiro S
    Hepatogastroenterology; 2002; 49(48):1625-31. PubMed ID: 12397750
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.